Showing results (1081-1090 of 5,480) with videos related to
Sort By:
Pageof 548
Pharmacotherapy|November 25, 2015
Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled TrialGiuseppe Derosa, Ivano Franzetti, Fabrizio Querci, et al.Pharmacotherapy|November 25, 2015
Making a Case for Pediatric Antimicrobial Stewardship ProgramsHeather K Magsarili, Jennifer E Girotto, Nicholas J Bennett, et al.Pharmacotherapy|February 6, 2016
Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research DatalinkKatrina Wilcox Hagberg, Vikrant V Sahasrabuddhe, Katherine A McGlynn, et al.Pharmacotherapy|April 5, 2016
Cobicistat Significantly Increases Tacrolimus Serum Concentrations in a Renal Transplant Recipient with Human Immunodeficiency Virus InfectionZhe Han, Brenna M Kane, Lindsay A Petty, et al.Pharmacotherapy|July 26, 2017
Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory SupportJ Erin Allender, Brent N Reed, Jenna L Foster, et al.Pharmacotherapy|August 24, 2017
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney DiseaseRishi J Desai, Julia Spoendlin, Helen Mogun, et al.Pharmacotherapy|July 10, 2016
Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic ResistanceChristine E Shulenberger, Anthony Jiang, Sandeep Devabhakthuni, et al.Pharmacotherapy|July 10, 2016
Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial TherapyLaura Means, Susan Bleasdale, Monica Sikka, et al.Pharmacotherapy|June 24, 2016
A Self-Assessment Guide for Resident Teaching ExperiencesJanet P Engle, Amy M Franks, Emily Ashjian, et al.Pharmacotherapy|June 14, 2016
Vedolizumab Compared with Certolizumab in the Therapy of Crohn Disease: A Systematic Review and Indirect ComparisonPaweł Kawalec, Pawel Moćko, Andrzej Pilc, et al.Pageof 548